OLMA Stock Analysis: Buy, Sell, or Hold?
OLMA - Olema Pharmaceuticals, Inc. Common Stock
$10.53
0.53 (5.30%)
▲
5d:
+6.58%
30d:
-25.11%
90d:
-24.62%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When OLMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OLMA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: OLMA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: OLMA is currently trading at $10.53, which is considered slightly low relative to its 30-day fair value range of $9.74 to $13.10.
Technical Outlook: Technically, OLMA is in a strong downtrend. Immediate support is located at $9.06, while resistance sits at $11.01. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: OLMA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.70 (+286.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OLMA is in a strong downtrend. Immediate support is located at $9.06, while resistance sits at $11.01. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: OLMA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.70 (+286.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.74 -
$13.10
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 286.5% below Wall St target ($40.70)
Trading Range Analysis
30-Day Trading Range
$9.74 -
$13.10
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$9.06
Resistance Level
$11.01
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.24
Wall Street Target
$40.70
(+286.5%)
Share & Embed Analysis
Last updated: June 23, 2026 7:46 PM ET
Data refreshes hourly during market hours. Next update: 8:46 PM
Data refreshes hourly during market hours. Next update: 8:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OLMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Shawnte Mitchell
SELL
25000 shares
2026-03-04
Shawnte Mitchell
SELL
15000 shares
2026-03-03
Cyrus Harmon
SELL
10000 shares
2026-01-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 57 HOLD |
Advanced OLMA Option Strategies
Professional options setups generated by AI based on today's OLMA price and gamma walls.
